51662-1242Level 3
NALOXONE HCI (NALOXONE HCI)
**Product type:** Human Prescription Drug
**Active ingredient:** NALOXONE HYDROCHLORIDE
**Strength:** .4 mg/mL
**Dosage form:** Injection, Solution
**Route:** Intramuscular; Intravenous; Subcutaneous
**Labeler:** HF Acquisition Co. LLC, DBA Health First
**Marketing category:** ANDA (ANDA070256)
**Pharmacologic class:** Opioid Antagonist [EPC], Opioid Antagonists [MoA]
GET
/api/v1/systems/ndc_fda/nodes/51662-1242Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.